WO1993018181A1 - Synthetic gene sequence for a signal peptide - Google Patents
Synthetic gene sequence for a signal peptide Download PDFInfo
- Publication number
- WO1993018181A1 WO1993018181A1 PCT/US1993/001494 US9301494W WO9318181A1 WO 1993018181 A1 WO1993018181 A1 WO 1993018181A1 US 9301494 W US9301494 W US 9301494W WO 9318181 A1 WO9318181 A1 WO 9318181A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- signal peptide
- dna molecule
- hybrid
- glucuronidase
- Prior art date
Links
- 108010076504 Protein Sorting Signals Proteins 0.000 title claims abstract description 65
- 108700005078 Synthetic Genes Proteins 0.000 title description 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 190
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 139
- 210000004027 cell Anatomy 0.000 claims abstract description 77
- 108020004414 DNA Proteins 0.000 claims abstract description 51
- 102000053602 DNA Human genes 0.000 claims abstract description 40
- 230000014509 gene expression Effects 0.000 claims abstract description 31
- 230000000694 effects Effects 0.000 claims abstract description 29
- 239000012634 fragment Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 24
- 101710196023 Vicilin Proteins 0.000 claims abstract description 22
- 210000002472 endoplasmic reticulum Anatomy 0.000 claims abstract description 17
- 230000008569 process Effects 0.000 claims abstract description 13
- 230000001681 protective effect Effects 0.000 claims abstract description 8
- 230000004927 fusion Effects 0.000 claims description 15
- 108020004511 Recombinant DNA Proteins 0.000 claims description 13
- 108010060309 Glucuronidase Proteins 0.000 claims description 12
- 102000053187 Glucuronidase Human genes 0.000 claims description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 239000013604 expression vector Substances 0.000 claims description 10
- 210000002288 golgi apparatus Anatomy 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 7
- 210000002421 cell wall Anatomy 0.000 claims description 7
- 230000013595 glycosylation Effects 0.000 claims description 7
- 238000006206 glycosylation reaction Methods 0.000 claims description 7
- 239000013598 vector Substances 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 6
- 230000002538 fungal effect Effects 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 108010053481 Antifreeze Proteins Proteins 0.000 claims description 3
- 230000004656 cell transport Effects 0.000 claims description 3
- 108020001507 fusion proteins Proteins 0.000 claims description 2
- 102000037865 fusion proteins Human genes 0.000 claims description 2
- 230000002101 lytic effect Effects 0.000 claims description 2
- 230000003248 secreting effect Effects 0.000 claims description 2
- 241000238631 Hexapoda Species 0.000 claims 4
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 claims 3
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 claims 3
- LPBUBIHAVKXUOT-FXQIFTODSA-N Cys-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N LPBUBIHAVKXUOT-FXQIFTODSA-N 0.000 claims 3
- SODXFJOPSCXOHE-IHRRRGAJSA-N Met-Leu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O SODXFJOPSCXOHE-IHRRRGAJSA-N 0.000 claims 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 239000002581 neurotoxin Substances 0.000 claims 1
- 231100000618 neurotoxin Toxicity 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 69
- 210000001938 protoplast Anatomy 0.000 description 26
- 244000061176 Nicotiana tabacum Species 0.000 description 19
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 18
- 230000028327 secretion Effects 0.000 description 18
- YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 description 14
- ZHSGGJXRNHWHRS-VIDYELAYSA-N tunicamycin Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](O)[C@@H](CC(O)[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(NC(=O)C=C2)=O)O)O1)O)NC(=O)/C=C/CC(C)C)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O ZHSGGJXRNHWHRS-VIDYELAYSA-N 0.000 description 14
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 14
- 210000003935 rough endoplasmic reticulum Anatomy 0.000 description 13
- 240000004713 Pisum sativum Species 0.000 description 12
- 235000010582 Pisum sativum Nutrition 0.000 description 12
- 230000009261 transgenic effect Effects 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 10
- 230000032258 transport Effects 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 230000001086 cytosolic effect Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 5
- 230000031787 nutrient reservoir activity Effects 0.000 description 5
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 5
- 210000003705 ribosome Anatomy 0.000 description 5
- 108010022172 Chitinases Proteins 0.000 description 4
- 102000012286 Chitinases Human genes 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241000219843 Pisum Species 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000011536 extraction buffer Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
- ARQXEQLMMNGFDU-JHZZJYKESA-N 4-methylumbelliferone beta-D-glucuronide Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ARQXEQLMMNGFDU-JHZZJYKESA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 241000208136 Nicotiana sylvestris Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010001267 Protein Subunits Proteins 0.000 description 2
- 102000002067 Protein Subunits Human genes 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical group 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000007421 fluorometric assay Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 102000035118 modified proteins Human genes 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000001254 nonsecretory effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 210000002729 polyribosome Anatomy 0.000 description 2
- 230000004481 post-translational protein modification Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 241001157784 Cercospora nicotianae Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 101100310856 Drosophila melanogaster spri gene Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 241000256023 Hyalophora cecropia Species 0.000 description 1
- 108700022013 Insecta cecropin B Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 101000763602 Manilkara zapota Thaumatin-like protein 1 Proteins 0.000 description 1
- 101000763586 Manilkara zapota Thaumatin-like protein 1a Proteins 0.000 description 1
- 101000966653 Musa acuminata Glucan endo-1,3-beta-glucosidase Proteins 0.000 description 1
- 230000004988 N-glycosylation Effects 0.000 description 1
- 241000208133 Nicotiana plumbaginifolia Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Chemical group 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 101710096342 Pathogenesis-related protein Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 101710163504 Phaseolin Proteins 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 241000269913 Pseudopleuronectes americanus Species 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008162 cell wall modification Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 230000003241 endoproteolytic effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000010189 intracellular transport Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 101150072645 pea gene Proteins 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical group [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000013606 secretion vector Substances 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000783 smooth endoplasmic reticulum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000011191 terminal modification Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8221—Transit peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Definitions
- the present invention relates generally to recombinantly produced proteins in plant cells and a process of transporting such proteins into the endoplasmic reticulum of plant cells, where they can subsequently be transported outside the cell or deposited in specific intracellular compartments.
- the endoplasmic reticulum plays a number of important functions.
- the smooth endoplasmic reticulum which lacks ribosomes, provides a site for synthesis and metabolism of fatty acids and phospholipids.
- the rough endoplasmic reticulum is studded with ribosomes which participate in the synthesis of cytoplasmic, membrane, and organelle proteins as well as in the synthesis of proteins to be secreted from the cell.
- RNA polymerase activates a control region on the gene which transcribes the DNA (i.e. encoded information) into messenger RNA. Transcription is ended by one or more "stop" codons on the gene.
- the messenger RNA is then translated into the encoded protein at the ribosomes bound to the rough endoplasmic reticulum.
- a growing polypeptide emerges from the ribosome, passes through the membrane of the rough endoplasmic reticulum, and accumulates in its lumen or central cavity.
- Proteins destined for direct transport include a lead signal peptide section, which is what directs the protein to enter the endoplasmic reticulum, and is then cleaved from the remainder of the protein after such entrance.
- proteins and membrane constituents are directed to their appropriate destinations. This is achieved by enzymatically modifying the proteins with a "tag" (e.g. , a carbohydrate or phosphate residue) to direct them to vesicles which transport the modified proteins outside the cell (or to intracellular compartments) .
- a "tag” e.g. , a carbohydrate or phosphate residue
- vicilins the major storage protein of developing legume seeds.
- Vicilins are synthesized as prepro-vi ⁇ ilins on membrane-bound ribosomes of the rough endoplasmic reticulum.
- prepro- vicilins pass into the lumen of the rough endoplasmic reticulum, their signal peptides are removed, as recognized by T.J.V. Higgins and D. Spencer, "Precursor forms of Pea Gene Encoding Vicilin Subunits," 67 Plant Phvsiol 205-11 (1981) , which is hereby incorporated by reference.
- the resulting peptides may then undergo various post-translational modifications.
- the protein in the lumen of the endoplasmic reticulum or in the Golgi complex, the protein may undergo glycosylation so that it is ready for intracellular transport, as recognized by B.S.L. Beevers, "Glycoprotein Metabolism in the Cotyledons of Pisum Sativum During Development and Germination," 57 Plant Ph ⁇ siol. 93-97 (1976) and R.A. Davey and .F. Dudman, "The Carbohydrate of Storage Glycoproteins from Seeds of Pisum Sativum: Characterization and Distribution of Component Polypeptides," 6 Aust. J. Plant Physiol.
- Boulter "Characterization of the Storage Protein Subunits Synthesized in vitro by Polyribosomes and RNA from Developing Pea (Pisum sativum L.), I.” 148 Le umin. Planta 49- 56 (1980); R.R.D. Croy, J.A. Gatehouse, I.M. Evans, and D. Boulter, "Characterization of the Storage Protein Subunits Synthesized in vitro by Polyribosomes and RNA from Developing Pea (Pisum sativum L.), II.” 148 Vicilin Planta 57-63 (1980); J.A. Gatehouse, R.R.D. Croy, H. Morton, M. Tyler, and D.
- heterologous genes i.e. DNA that encodes proteins not ordinarily produced by the host organism containing that vehicle.
- a heterologous gene is first inserted into a closing vector, such as a plasmid.
- the vector is then transfected into the host cells, which are thereafter transformed.
- the tranformed cells then multiply to increase the population containing copies of the gene to be expressed in the host cell for production of a protein foreign to that cell.
- the signal peptides were derived from gene fragments encoding for the pathogenesis-related protein 16(sPRI) , a protein secreted in tobacco mosaic virus-infected tobacco leaves-, and the prepro-peptide of cecropin B(sCEC), a peptide secreted into the hemolymph of the insect Hyalophora cecropia. It was found that the total level of enzyme expression was lower in secretion constructs (with the signal peptide sequence) than for unmodified genes which encoded for the enzyme alone.
- genes encoding for a hybrid protein consisting of a signal peptide sequence fused to another protein for the purpose of secretion is thus well known in plant cells.
- these signal peptides are not satisfactory, because they do not achieve high expression levels and, in fact, decrease the expression level of the desired proteins. Accordingly, the need exists for effective signal peptide sequences which can maintain or enhance high expression levels of desired proteins in plant cells.
- the present invention relates to a process of transporting a desired protein to the endoplasmic reticulum of plant cells for secretion.
- This process utilizes a DNA molecule encoding for a hybrid protein which includes a first protein containing a signal peptide, as described below, which was derived from the putative published sequence for the vicilin signal peptide, or its homologs, or any fragments thereof fused to a second protein which confers an extracellular protective or other desired effect in plant cells.
- the second protein may be a protein or fragment thereof which imparts bacterial, fungal, or freeze resistance outside the cell walls of plant cells transformed with an expression system in which that DNA molecule is cloned.
- the DNA molecule encoding the hybrid protein of the present invention may be cloned into an expression vector (e.g., a plasmid) to form a recombinant DNA expression system. This system is then transfected into plant cells. The plant cells of the present invention are then transformed and grown in a suitable medium to increase the number of such transformed cells. The transformed cells thus express the DNA encoding the hybrid protein of the present invention.
- the hybrid protein includes the signal peptide described below, its homologs, or any fragment thereof which directs transport of the second protein into the endoplasmic reticulum. The signal peptide is cleaved off upon entry into the rough endoplasmic reticulum.
- the second protein which is the protein of interest, is further modified in the endoplasmic reticulum lumen or in the Golgi complex and then secreted outside the plant cell or otherwise transported within the cell. Any plant cell transformed with this recombinant DNA expression system may then secrete the desired protein.
- This system can be used to secrete proteins which will condition resistance to bacteria, fungi, or frost, or will affect plant cell walls or function as markers or tags or color factors.
- Figure IB shows the 5' end of the hybrid gene encoding for the signal peptide and j8-glucuronidase, and the corresponding amino acids.
- Figure 2A is a graph showing the 0-glucuronidase activity for transformed leaf cells of transgenic tobacco plants.
- Figure 2B is a graph showing the ⁇ -glucuronidase activity for transformed root cells of transgenic tobacco plants.
- Figure 3A shows a chart of the distribution of transient
- Figure 3B shows a chart of the distribution of transient j3-glucuronidase activity in transformed tobacco protoplasts in the presence of tunicamycin.
- Figure 4 is a chart showing the total transient ⁇ - glucuronidase activity (pooled from all fractions) in transformed protoplasts in the presence of tunicamycin.
- the present invention relates to a process of transporting proteins to the endoplasmic reticulum of plant cells for secretion or other targeting within the cell.
- This process utilizes a DNA molecule encoding a hybrid protein.
- the hybrid protein includes a first part of the protein which contains a signal peptide derived from a putative sequence for the vicilin protein, its homologs, or any fragments thereof.
- This first protein is fused to a second protein which confers an extracellular protective effect in plant calls or any other desired effect such as for marking, color, cell wall modification, etc.
- the signal peptide, its homologs, or fragments thereof is present to enable the hybrid protein to enter the cell's transport pathway via the endoplasmic reticulum.
- the signal peptide Upon entry into the lumen, the signal peptide is cleaved from the second protein in the same fashion as the vicilin signal peptide would be separated from the vicilin protein to which it is fused in nature.
- the second protein can then be processed in the Golgi complex or in the endoplasmic reticulum lumen for extracellular secretion or transport within the cell.
- the DNA molecule of the present invention encodes for an amino acid signal sequence substantially corresponding to the sequence:
- the second protein is a protein or fragment thereof which imparts a resistance to bacteria, fungi, or freezing or any other desired effect.
- the synthetic sequence derived from the Pisum vicilin signal peptide is effective in producing a hybrid protein which includes and carries a second protein into the cell transport path. As a result the resistance provided by the second protein is imparted to plants extracellularly (i.e. outside the cell wall, particularly to extracellular surfaces of the plant cell walls) .
- proteins which may impart extracellular bacterial resistance to plants include lytic proteins. See, e.g., L. Destefano-Beltran, "Enhancing Bacterial and Fungal Disease Resistance in Plants: Application to Potato," Molecular Biology of the Potato, p. 205-21 (1990) , which is hereby incorporated by reference.
- proteins which may impart extracellular fungal resistance to plants include chitinases and glucanases. See, e.g., C. Castresana, "Tissue-Specific and Pathogen-Induced Regulation of a Nicotiana plumbaginifolia ⁇ - 1,3-Glucanase Gene," 2 The Plant Cell. 1131-43 (1990); J. Neuhaus, "High-level Expression of a Tobacco Chitanase Gene in Nicotiana sylvestris . Susceptibility of Transgenic Plants to Cercospora Nicotianae Infection," 16 Plant Molec. Biol. 141-51 (1991) ; and L. Destefano-Beltran, "Enhancing Bacterial and Fungal Disease Resistance in Plants: Application to Potato,” Molecular Biology of the Potato, p. 205-21 (1990), all of which are hereby incorporated by reference.
- proteins which may impart extracellular antifreezing capability in plants include numerous fish antifreeze peptides. See, e.g., P.L. Davies, "Antifreeze Protein Genes of the Winter Flounder," 259 J. Biol. Chem. 9241-47 (1984) , which is hereby incorporated by reference.
- the second protein may include polygalacturonase, /3-glucuronidase, other marker proteins, and their homologs, fragments, or portions thereof.
- jS-glucuronidase primarily serves as an example.
- the gene encoding for jS-glucuronidase is a widely used marker gene having a well known sequence and known to be useful in forming N-terminal fusions. See, e.g., R.A. Jefferson, "Assaying Chimeric Genes in Plants: The GUS Gene Fusion System," 5 Plant Molecular Biology Reporter. 387-405 (1987) and R.A. Jefferson, "j ⁇ -Glucuronidase from Escherichia coli as a Gene-fusion Marker," 83 Proc.
- the polypeptide formed from the fusion of the first protein to the second protein is a hybrid in that the first and second proteins are not normally joined in nature. Likewise, the corresponding portions of the DNA molecule encoding each of these proteins makes the DNA molecule a hybrid.
- the portion of the DNA molecule encoding the first protein is fused in proper orientation and correct reading frame to that part of the DNA molecule encoding the second protein.
- a linker sequence connects these portions of the DNA molecule.
- the expression vector into which this fusion DNA molecule is inserted includes a promoter sequence which functions to regulate polypeptide expression.
- a wide variety of promoters may be utilized, such as the 35S promoter of cauliflower mosaic virus.
- the DNA molecule encoding for the hybrid protein of the present invention is inserted into an expression system to which the DNA molecule is heterologous (i.e., not normally present) .
- the heterologous DNA molecule is inserted into the expression system or vector in proper orientation and correct reading frame.
- plasmids include pBI426 and pMON316, preferably pMON316.
- the expression system of the present invention can be used to transform virtually any crop plant cell under suitable conditions. Such cells are transformed with the DNA molecule of the present invention by conventional procedures. Cells transformed in accordance with the present invention can be grown in vitro in a suitable medium to produce the desired second protein. This protein can then be harvested or recovered by conventional purification techniques. Alternatively, transformed cells can be regenerated into whole plants such that secreted proteins impart desired characteristics to the intact plants.
- DNA molecule of the present invention Regardless of whether the DNA molecule of the present invention is expressed in intact plants or in culture, expression of the desired protein follows essentially the same basic mechanism. Specifically, transcription of the DNA molecule is initiated by the binding of RNA polymerase to the DNA molecule's promoter. During transcription, movement of the RNA polymerase along the DNA molecule forms messenger RNA. As a result, the DNA molecule that encodes for the hybrid protein of the present invention is transcribed into the corresponding messenger RNA. This messenger RNA then moves to the ribosomes of the rough endoplasmic reticulum which, with transfer RNA, translates the messenger RNA into the hybrid protein of the present invention.
- the resulting hybrid protein passes into the lumen of the rough endoplasmic reticulum.
- the signal sequence i.e., the first protein, its homolog, or a fragment thereof
- the second protein having the ability to confer desired effects will continue to advance into the lumen in an unfused state.
- This protein is then modified by glycosylation in the lumen or in Golgi complex.
- the modified protein is then secreted by the Golgi complex to a location outside the host cell or is transported within the cell to a specific site.
- Complementary oligodeoxyribonucleotides of each segment were then annealed by combining 0.2 nmole of each, and incubating the mixture at 90°C for 10 minutes, at 65°C for 2 hours, and at room temperature (i.e. 32°C) overnight.
- the resulting DNA fragment was then purified from a polyacrylamide gel and used for construction of plant j8-glucuronidase-secretion vector through a multiple-step procedure.
- the gene encoding jS-glucuronidase was excised from the plas id pBI101.3 (Clontech Laboratories, Inc.) with Hindlll+SstI , and ligated into the vector p ⁇ Cll ⁇ . See, J. Vieira and J. Messing, "Production of Single-stranded Plasmid DNA," 153 Methods Enzymol 3-11 (1987) , which is hereby incorporated by , reference, that had been cut with Hindlll+SstI .
- a Kpnl linker ( ⁇ '-GGGTACCC) and a Hindlll linker (5'CCAAGCTTGG) were inserted into the unique Hindlll and Smal sites upstream of the gene encoding ⁇ -glucuronidase in the resulting p ⁇ C118- ⁇ -glucuronidase in the resulting p ⁇ C118- ⁇ -glucuronidase plasmid.
- the purified signal peptide fragment was then fused in-frame to the N-terminus of the gene encoding ⁇ -glucuronidase to form pUC118- ⁇ -glucuronidasel, by replacing the Kpnl-Hindlll multi-cloning fragment of the modified p ⁇ cll8- ⁇ -glucuronidase with the assembled signal peptide-encoding fragment.
- the fusion region of the hybrid gene in pUC118- ⁇ -glucuronidasel ( Figure 1) was sequenced by the dideoxy chain-termination method of F. Sanger, S. Nicklen, and A.R. Coulson, "DNA Sequencing with Chain-terminating Inhibitors," 74 Proc. Natl. Acad. Sci. USA 5463-67 (1977), the disclosure of which is hereby incorporated by reference, using the universal M13 primer.
- the KpnI-EcoRI fragment coding for the signal peptide//3-glucuronidase fusion was isolated from pUcll8- ⁇ -glucuronidasel and cloned into the plant expression vector pMON316. See, S.G. Rogers, H.J.
- Plasmid pM0N316- ⁇ -glucuronidasel-2 was similarly constructed, according to the above-described procedures in an independent cloning experiment.
- the 3-glucuronidase-encoding sequence was closed into pMON316 in both orientations to generate positive (pMON316- ⁇ -glucuronidase (+) ) and negative (p ⁇ fON31t5-3-grIu ⁇ uronidase (-) ) controls for expression of the gene encoding for
- the fusion gene was then placed under the 35S promoter of cauliflower mosaic virus in a plant expression vector, and introduced into tobacco protoplasts for transient expression, and into tobacco leaf discs/NTl cells for stable transformation, using conventional recombinant technology procedures.
- Leaf discs from in vitro grown plantlets were transformed using an improved biolistic device of G.N. Ye, M. Daniell, and J.C. Sanford, "Optimization of Delivery of Foreign Gene into Higher Plant Chloroplasts," 15 Plant Mol. Biol. 809-19 (1990) , which is hereby incorporated by reference, and transformants were selected on kanamycin medium following two days of incubation on non-selective medium.
- Transgenic plants from leaf discs were regenerated from shoots after transfer to a hormone-free tobacco medium. 20 ⁇ g tunicamycin per ml was added to the culture medium to inhibit glycosylation of the fusion -glucuronidase.
- Leaf or root extracts were prepared by grinding in the extraction buffer (50 mM Tris-HCl, pH 7.5/0.15 mg phenylmethylsulfonyl fluoride/0.3 mg dithiothreitol/0.3 mg bovine serum albumin, all per ml) and removing the cell debris by centrifugation.
- the /3-glucuronidase fluorometric assay described by J.H. Gould and R.M. Smith "A Non-destructive Assay for 0-glucuronidase in the Media of Plant Tissue Cultures," 7 Plant Mol. Biol. Rep.
- GUS(-) and GUS(+) represent the plants transformed with pMON316- ⁇ -glucuronidase (-) and pMON316- ⁇ -glucuronidase (+) , respectively, while GUSl-1 and GUS1-2 represent plants transformed with the similar vicilin(s) signal peptide/3-glucuronidase-encoding constructs pMON316- ⁇ -glucuronidasel-l and pMON316- ⁇ -glucuronidase 1-2.
- pMON316- ⁇ -glucuronidase (-) Since the fusion region of the hybrid gene encoding for jS-glucuronidase was sequenced, and confirmed to be correct, the absence of 8-glucuronidase activity in the plants containing the fusion gene must be attributed to the interference of gene expression by the addition of the signal peptide sequence. Alternatively, the gene fusion or post-translational modification of the fusion protein in the transport pathway could cause loss of /3-glucuronidase activity.
- Protoplasts were prepared from leaves derived from seedlings of N. tabacum var Havana cv 423 grown in vitro at low light intensity, generally as described by J.I. Negy and P. Maliga, "Callus Induction and Plant Regeneration from Mesophyll Protoplasts of Nicotiana Sylvestris.” 78 Z. convincedvsiol 453-55 (1976) , which disclosure is hereby incorporated by reference, with some modifications. Briefly, the sliced leaves were digested in an isolation medium containing 1.25% Cellulase RIO and 0.4% Macerozyme RIO (Karlan Chemical Corporation, Torrance, CA) at 26°C overnight.
- the protoplasts at the interface were transferred to new tubes and washed with W5 solution.
- the isolated protoplasts were transformed with the plasmid constructs described above using the polyethylene glycol method of Negrutiu.
- the transformed protoplasts were then cultured at the final density of lxlO 6 protoplasts/ml in the culture medium (containing 20 ⁇ g tunicamycin/ml where indicated) at 26°C in the dark.
- the transformed tobacco protoplasts were fractionated into extracellular, cytoplasmic and membrane-associated fractions about 50 hours after the polyethylene glycol-mediated transformation.
- the extracellular fraction (the culture medium) was collected as supernatant from the protoplast cultures following centrifugation at lOOxg for 5 minutes.
- the pelleted protoplasts were washed once in W5 solution and lysed by osmotic shock in an appropriate volume of extraction buffer
- the transport system appears to become saturated or partially blocked, resulting in accumulation of 3-glucuronidase in the cytoplasm.
- the protoplasts transiently expressing the hybrid gene produced 10-30 fold more j8-glucuronidase protein (Fig. 4) than the transgenic plants containing the same construct (Fig. 2) .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to a process of transporting a desired protein into the endoplasmic reticulum of plant cells for transport within or outside the cell. This process utilizes a DNA molecule encoding for a hybrid protein. The encoded hybrid protein includes a first protein including a signal peptide derived from a putative vicilin signal peptide, its homolog, or a fragment thereof and a second protein which confers an extracellular protective effect or another desired effect in plant cells. This DNA molecule can be inserted into an expression system which can then be used to transform cells that will direct the desired second protein into its transport system.
Description
SYNTHETIC GENE SEQUENCE FOR A SIGNAL PEPTIDE
FIELD OF THE INVENTION
The present invention relates generally to recombinantly produced proteins in plant cells and a process of transporting such proteins into the endoplasmic reticulum of plant cells, where they can subsequently be transported outside the cell or deposited in specific intracellular compartments.
BACKGROUND OF THE INVENTION
In eucaryotic cells, the endoplasmic reticulum plays a number of important functions. The smooth endoplasmic reticulum, which lacks ribosomes, provides a site for synthesis and metabolism of fatty acids and phospholipids. The rough endoplasmic reticulum is studded with ribosomes which participate in the synthesis of cytoplasmic, membrane, and organelle proteins as well as in the synthesis of proteins to be secreted from the cell.
In producing a protein, which is to be secreted or deposited in a specific intracellular compartment, the gene containing the DNA encoding the desired protein is expressed. During such expression, RNA polymerase activates a control region on the gene which transcribes the DNA (i.e. encoded information) into messenger RNA. Transcription is ended by one or more "stop" codons on the gene. The messenger RNA is then translated into the encoded protein at the ribosomes bound to the rough endoplasmic reticulum. During translation of the information from the messenger RNA, a growing polypeptide emerges from the ribosome, passes through the membrane of the rough endoplasmic reticulum, and accumulates in its lumen or central cavity. Proteins destined for direct transport include a lead signal peptide section, which is what directs the protein to enter the endoplasmic reticulum, and is
then cleaved from the remainder of the protein after such entrance.
After synthesis, transported proteins in the rough endoplasmic reticulum move to the lumen cavity of the Golgi complex. In the Golgi complex, proteins and membrane constituents are directed to their appropriate destinations. This is achieved by enzymatically modifying the proteins with a "tag" (e.g. , a carbohydrate or phosphate residue) to direct them to vesicles which transport the modified proteins outside the cell (or to intracellular compartments) .
In plant cells, a variety of naturally occurring proteins are transported by the above-described mechanism. An example of such proteins are the vicilins, the major storage protein of developing legume seeds. Vicilins are synthesized as prepro-viσilins on membrane-bound ribosomes of the rough endoplasmic reticulum. As prepro- vicilins pass into the lumen of the rough endoplasmic reticulum, their signal peptides are removed, as recognized by T.J.V. Higgins and D. Spencer, "Precursor forms of Pea Gene Encoding Vicilin Subunits," 67 Plant Phvsiol 205-11 (1981) , which is hereby incorporated by reference. The resulting peptides may then undergo various post-translational modifications. For example, in the lumen of the endoplasmic reticulum or in the Golgi complex, the protein may undergo glycosylation so that it is ready for intracellular transport, as recognized by B.S.L. Beevers, "Glycoprotein Metabolism in the Cotyledons of Pisum Sativum During Development and Germination," 57 Plant Phγsiol. 93-97 (1976) and R.A. Davey and .F. Dudman, "The Carbohydrate of Storage Glycoproteins from Seeds of Pisum Sativum: Characterization and Distribution of Component Polypeptides," 6 Aust. J. Plant Physiol. , 435-47 (1979) , which are hereby incorporated by reference. After being directed into "protein bodies" within the cell, vicilins can undergo endoproteolytic cleavage to form a wide range of smaller molecular weight proteins, as disclosed by M.J. Chrispeels, T.S.V. Higgins, and D. Spence, "Assembly of Storage Protein Oligomers in the Endoplasmic Reticulum and Processing of the Polypeptides in
the Protein Bodies of Developing Pea Cotyledons," 93 J. Cell Biol. 306-13 (1982); R.R.D. Croy, J.A. Gatehouse, I.M. Evans, and D. Boulter, "Characterization of the Storage Protein Subunits Synthesized in vitro by Polyribosomes and RNA from Developing Pea (Pisum sativum L.), I." 148 Le umin. Planta 49- 56 (1980); R.R.D. Croy, J.A. Gatehouse, I.M. Evans, and D. Boulter, "Characterization of the Storage Protein Subunits Synthesized in vitro by Polyribosomes and RNA from Developing Pea (Pisum sativum L.), II." 148 Vicilin Planta 57-63 (1980); J.A. Gatehouse, R.R.D. Croy, H. Morton, M. Tyler, and D. Boulter, "Characterization and Subunit Structures of the Gene Encoding Vicilin Storage Proteins of Peas (Pisum sativum L.)," 118 Eur. J. Biochem. 627-633 (1981); and D. Spencer and T.J.V. Higgins "The Biosynthesis of Legumin in the Maturing Pea Seeds," 1 Biochem. Int. 502-09 (1980), which are hereby incorporated by reference.
In recent years, advances in biochemistry have led to the preparation of recombinant cloning vehicles (e.g., plasmids) containing heterologous genes (i.e. DNA that encodes proteins not ordinarily produced by the host organism containing that vehicle) . Briefly, a heterologous gene is first inserted into a closing vector, such as a plasmid. The vector is then transfected into the host cells, which are thereafter transformed. The tranformed cells then multiply to increase the population containing copies of the gene to be expressed in the host cell for production of a protein foreign to that cell.
In plant cells, recombinant DNA techniques have been utilized to produce a number of proteins suitable for extracellular secretion.
In J. Denecke et al., "Protein Secretion in Plant Cells Can Occur via a Default Pathway," 2 The Plant Cell. 51- 59 (1990) , the non-secretory enzymes phosphinothricin acetyl transferase, neomycin phosphotransferase II, and β- glucuronidase were secreted from plant cells when targeted to the endoplasmic reticulum lumen by signal peptide-mediated translocation. The signal peptides were derived from gene
fragments encoding for the pathogenesis-related protein 16(sPRI) , a protein secreted in tobacco mosaic virus-infected tobacco leaves-, and the prepro-peptide of cecropin B(sCEC), a peptide secreted into the hemolymph of the insect Hyalophora cecropia. It was found that the total level of enzyme expression was lower in secretion constructs (with the signal peptide sequence) than for unmodified genes which encoded for the enzyme alone.
In P. Lund et al., "Bacterial Chitinase is Modified and Secreted in Transgenic Tobacco," 91 Plant Physiol.. 130-35 (1989) , a gene encoding for bacterial chitinase and its natural signal sequence was cloned in plant cells. Bacterial chitinase was ultimately secreted from the plant cell.
G. Iturriaga et al., "Endoplasmic Reticulum Targeting and Glycosylation of Hybrid Proteins in Transgenic Tobacco," 1 The Plant Cell. 381-90 (1989) prepared a gene encoding for a hybrid protein of the putative signal peptide of patatin fused to /3-glucuronidase. When the gene was cloned and expressed in plant cells, it was found that the patatin was cleaved from the resulting protein, and the β- glucuronidase was expressed. Again, however, the total level of jS-glucuronidase was very low compared to non-secretory controls.
The use of genes encoding for a hybrid protein consisting of a signal peptide sequence fused to another protein for the purpose of secretion is thus well known in plant cells. However, these signal peptides are not satisfactory, because they do not achieve high expression levels and, in fact, decrease the expression level of the desired proteins. Accordingly, the need exists for effective signal peptide sequences which can maintain or enhance high expression levels of desired proteins in plant cells.
SUMMARY OF THE INVENTION
The present invention relates to a process of transporting a desired protein to the endoplasmic reticulum of
plant cells for secretion. This process utilizes a DNA molecule encoding for a hybrid protein which includes a first protein containing a signal peptide, as described below, which was derived from the putative published sequence for the vicilin signal peptide, or its homologs, or any fragments thereof fused to a second protein which confers an extracellular protective or other desired effect in plant cells. For example, the second protein may be a protein or fragment thereof which imparts bacterial, fungal, or freeze resistance outside the cell walls of plant cells transformed with an expression system in which that DNA molecule is cloned.
The DNA molecule encoding the hybrid protein of the present invention may be cloned into an expression vector (e.g., a plasmid) to form a recombinant DNA expression system. This system is then transfected into plant cells. The plant cells of the present invention are then transformed and grown in a suitable medium to increase the number of such transformed cells. The transformed cells thus express the DNA encoding the hybrid protein of the present invention. The hybrid protein includes the signal peptide described below, its homologs, or any fragment thereof which directs transport of the second protein into the endoplasmic reticulum. The signal peptide is cleaved off upon entry into the rough endoplasmic reticulum. The second protein, which is the protein of interest, is further modified in the endoplasmic reticulum lumen or in the Golgi complex and then secreted outside the plant cell or otherwise transported within the cell. Any plant cell transformed with this recombinant DNA expression system may then secrete the desired protein. This system can be used to secrete proteins which will condition resistance to bacteria, fungi, or frost, or will affect plant cell walls or function as markers or tags or color factors.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure IA shows the oligodeoxyribonucleotide signal sequence for the hybrid gene of the present invention.
Figure IB shows the 5' end of the hybrid gene encoding for the signal peptide and j8-glucuronidase, and the corresponding amino acids.
Figure 2A is a graph showing the 0-glucuronidase activity for transformed leaf cells of transgenic tobacco plants.
Figure 2B is a graph showing the β-glucuronidase activity for transformed root cells of transgenic tobacco plants.
Figure 3A shows a chart of the distribution of transient |8-glucuronidase activity in transformed tobacco protoplasts in the absence of tunicamycin.
Figure 3B shows a chart of the distribution of transient j3-glucuronidase activity in transformed tobacco protoplasts in the presence of tunicamycin.
Figure 4 is a chart showing the total transient β- glucuronidase activity (pooled from all fractions) in transformed protoplasts in the presence of tunicamycin.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a process of transporting proteins to the endoplasmic reticulum of plant cells for secretion or other targeting within the cell. This process utilizes a DNA molecule encoding a hybrid protein. The hybrid protein includes a first part of the protein which contains a signal peptide derived from a putative sequence for the vicilin protein, its homologs, or any fragments thereof. This first protein is fused to a second protein which confers an extracellular protective effect in plant calls or any other desired effect such as for marking, color, cell wall modification, etc.
The signal peptide, its homologs, or fragments thereof is present to enable the hybrid protein to enter the cell's transport pathway via the endoplasmic reticulum. Upon
entry into the lumen, the signal peptide is cleaved from the second protein in the same fashion as the vicilin signal peptide would be separated from the vicilin protein to which it is fused in nature. The second protein can then be processed in the Golgi complex or in the endoplasmic reticulum lumen for extracellular secretion or transport within the cell.
Preferably, the DNA molecule of the present invention encodes for an amino acid signal sequence substantially corresponding to the sequence:
Met Leu Leu Ala lie Ala Phe.Leu Ala Ser Val Cys Val Ser Ser.
G.W. Lycett, A.J. Delauney, J.A. Gatehouse, J. Gilroy, R.R.D. Croy, and D. Boulter, "The Gene Encoding Vicilin Gene Family of Pea (Pisum Sativum L.) : A Complete cDNA Coding Sequence for Preprogene Encoding Vicilin, " 11 Nucleic Acids Res. 2367-80 (1983) predicts this putative signal peptide sequence from the cDNA sequence for a 47 kDA prepro-vicilin polypeptide, but does not disclose a specific gene encoding for this amino acid sequence. The accuracy of this amino acid sequence prediction is questionable. Moreover, the initial methione predicted by Lycett, et al. may, in fact, not be the true N-terminus of the peptide but may represent the truncation of the natural signal peptide. In any event, based on the amino acid sequence disclosed by Lycett, a synthetic DNA sequence encoding for that signal sequence has been prepared as follows:
ATG TTA TTA GCT ATT GCA TTT TTA GCA TCA GTT TGT GTT TCA TAC ATT AAT CGA TAA CGT AAA AAT CGT AGT CAA ACA CAA AGT.
The second protein is a protein or fragment thereof which imparts a resistance to bacteria, fungi, or freezing or any other desired effect. The synthetic sequence derived from the Pisum vicilin signal peptide is effective in producing a hybrid protein which includes and carries a second protein
into the cell transport path. As a result the resistance provided by the second protein is imparted to plants extracellularly (i.e. outside the cell wall, particularly to extracellular surfaces of the plant cell walls) .
Examples of proteins which may impart extracellular bacterial resistance to plants include lytic proteins. See, e.g., L. Destefano-Beltran, "Enhancing Bacterial and Fungal Disease Resistance in Plants: Application to Potato," Molecular Biology of the Potato, p. 205-21 (1990) , which is hereby incorporated by reference.
Examples of proteins which may impart extracellular fungal resistance to plants include chitinases and glucanases. See, e.g., C. Castresana, "Tissue-Specific and Pathogen-Induced Regulation of a Nicotiana plumbaginifolia β- 1,3-Glucanase Gene," 2 The Plant Cell. 1131-43 (1990); J. Neuhaus, "High-level Expression of a Tobacco Chitanase Gene in Nicotiana sylvestris . Susceptibility of Transgenic Plants to Cercospora Nicotianae Infection," 16 Plant Molec. Biol. 141-51 (1991) ; and L. Destefano-Beltran, "Enhancing Bacterial and Fungal Disease Resistance in Plants: Application to Potato," Molecular Biology of the Potato, p. 205-21 (1990), all of which are hereby incorporated by reference.
Examples of proteins which may impart extracellular antifreezing capability in plants include numerous fish antifreeze peptides. See, e.g., P.L. Davies, "Antifreeze Protein Genes of the Winter Flounder," 259 J. Biol. Chem. 9241-47 (1984) , which is hereby incorporated by reference.
The second protein may include polygalacturonase, /3-glucuronidase, other marker proteins, and their homologs, fragments, or portions thereof. Of these proteins, jS-glucuronidase primarily serves as an example. The gene encoding for jS-glucuronidase is a widely used marker gene having a well known sequence and known to be useful in forming N-terminal fusions. See, e.g., R.A. Jefferson, "Assaying Chimeric Genes in Plants: The GUS Gene Fusion System," 5 Plant Molecular Biology Reporter. 387-405 (1987) and R.A. Jefferson, "jδ-Glucuronidase from Escherichia coli as a
Gene-fusion Marker," 83 Proc. Nat. Acad. Sci.f 8447-51 (1986), both of which are hereby incorporated by reference. The hybrid gene encoding for a hybrid protein containing β-glucuronidase and the amino acid which that gene encodes is shown in Figure IB.
The polypeptide formed from the fusion of the first protein to the second protein is a hybrid in that the first and second proteins are not normally joined in nature. Likewise, the corresponding portions of the DNA molecule encoding each of these proteins makes the DNA molecule a hybrid.
The portion of the DNA molecule encoding the first protein is fused in proper orientation and correct reading frame to that part of the DNA molecule encoding the second protein. In Figure IB, a linker sequence connects these portions of the DNA molecule.
The expression vector into which this fusion DNA molecule is inserted includes a promoter sequence which functions to regulate polypeptide expression. A wide variety of promoters may be utilized, such as the 35S promoter of cauliflower mosaic virus.
The DNA molecule encoding for the hybrid protein of the present invention is inserted into an expression system to which the DNA molecule is heterologous (i.e., not normally present) . The heterologous DNA molecule is inserted into the expression system or vector in proper orientation and correct reading frame. Although a wide variety of expression systems can be utilized, the use of plasmids is particularly desirable. Suitable plasmids include pBI426 and pMON316, preferably pMON316.
The expression system of the present invention can be used to transform virtually any crop plant cell under suitable conditions. Such cells are transformed with the DNA molecule of the present invention by conventional procedures. Cells transformed in accordance with the present invention can be grown in vitro in a suitable medium to produce the desired second protein. This protein can then be harvested or
recovered by conventional purification techniques. Alternatively, transformed cells can be regenerated into whole plants such that secreted proteins impart desired characteristics to the intact plants.
Regardless of whether the DNA molecule of the present invention is expressed in intact plants or in culture, expression of the desired protein follows essentially the same basic mechanism. Specifically, transcription of the DNA molecule is initiated by the binding of RNA polymerase to the DNA molecule's promoter. During transcription, movement of the RNA polymerase along the DNA molecule forms messenger RNA. As a result, the DNA molecule that encodes for the hybrid protein of the present invention is transcribed into the corresponding messenger RNA. This messenger RNA then moves to the ribosomes of the rough endoplasmic reticulum which, with transfer RNA, translates the messenger RNA into the hybrid protein of the present invention. During translation of the messenger RNA, the resulting hybrid protein passes into the lumen of the rough endoplasmic reticulum. After the signal sequence (i.e., the first protein, its homolog, or a fragment thereof) is cleaved at the site shown in Figure IB, the second protein having the ability to confer desired effects will continue to advance into the lumen in an unfused state. This protein is then modified by glycosylation in the lumen or in Golgi complex. The modified protein is then secreted by the Golgi complex to a location outside the host cell or is transported within the cell to a specific site.
EXAMPLES
Example l — Construction of Plant Expression Vector for Secretion of /S-Glucuronidase
Sequences of component oligodeoxyribonucleotides (Figure IA) coding for the N-terminus of the hybrid gene (DNA) encoding a signal peptide derived from the putative vicilin signal peptide and /3-glucuronidase (Figure IB) were prepared
by the following procedure. The oligodeoxyribonucleotides #1- #4 (Figure IA) used to assemble the signal peptide sequence of Pisum vicilin (s) were synthesized using a conventional DNA synthesizer. The oligodeoxyribonucleotides #2 and #3 were phosphorylated by BRL T4 polynucleotide kinase. Complementary oligodeoxyribonucleotides of each segment were then annealed by combining 0.2 nmole of each, and incubating the mixture at 90°C for 10 minutes, at 65°C for 2 hours, and at room temperature (i.e. 32°C) overnight. The entire signal peptide sequence, with a 5' terminal Kpnl site and a 3' terminal blunt end, was assembled from the two annealed segments (0.2 nmole each) using standard ligation procedures. The resulting DNA fragment was then purified from a polyacrylamide gel and used for construction of plant j8-glucuronidase-secretion vector through a multiple-step procedure. The gene encoding jS-glucuronidase was excised from the plas id pBI101.3 (Clontech Laboratories, Inc.) with Hindlll+SstI , and ligated into the vector pϋCllβ . See, J. Vieira and J. Messing, "Production of Single-stranded Plasmid DNA," 153 Methods Enzymol 3-11 (1987) , which is hereby incorporated by , reference, that had been cut with Hindlll+SstI . In order properly to fuse the synthesized signal peptide-encoding nucleotide sequence to the N-terminus of the gene encoding β-glucuronidase, a Kpnl linker (δ'-GGGTACCC) and a Hindlll linker (5'CCAAGCTTGG) were inserted into the unique Hindlll and Smal sites upstream of the gene encoding β-glucuronidase in the resulting pϋC118-β-glucuronidase in the resulting pϋC118-β-glucuronidase plasmid. The purified signal peptide fragment was then fused in-frame to the N-terminus of the gene encoding β-glucuronidase to form pUC118-β-glucuronidasel, by replacing the Kpnl-Hindlll multi-cloning fragment of the modified pϋcll8-β-glucuronidase with the assembled signal peptide-encoding fragment.
The fusion region of the hybrid gene in pUC118-β-glucuronidasel (Figure 1) was sequenced by the dideoxy chain-termination method of F. Sanger, S. Nicklen, and A.R. Coulson, "DNA Sequencing with Chain-terminating
Inhibitors," 74 Proc. Natl. Acad. Sci. USA 5463-67 (1977), the disclosure of which is hereby incorporated by reference, using the universal M13 primer. Finally, the KpnI-EcoRI fragment coding for the signal peptide//3-glucuronidase fusion was isolated from pUcll8-β-glucuronidasel and cloned into the plant expression vector pMON316. See, S.G. Rogers, H.J. Klee, R.B. Horsch, and R.T. Fraley, "Improved Vectors for Plant Transformation: Expression Cassette Vectors and New Selectable Markers," 153 Methods Enzv ol. 253-77 (1987), previously digested with _K nT+_EcoI?T. The resulting plasmid was designated pM0N316-β-glucuronidasel-l . Plasmid pM0N316-β-glucuronidasel-2 was similarly constructed, according to the above-described procedures in an independent cloning experiment. The 3-glucuronidase-encoding sequence, without the signal peptide, was closed into pMON316 in both orientations to generate positive (pMON316-β-glucuronidase (+) ) and negative (pΛfON31t5-3-grIuσuronidase (-) ) controls for expression of the gene encoding for |8-glucuronidase.
The fusion gene was then placed under the 35S promoter of cauliflower mosaic virus in a plant expression vector, and introduced into tobacco protoplasts for transient expression, and into tobacco leaf discs/NTl cells for stable transformation, using conventional recombinant technology procedures.
Example 2 — Analysis for the Presence of /3-glucuronidase
Leaf discs from in vitro grown plantlets were transformed using an improved biolistic device of G.N. Ye, M. Daniell, and J.C. Sanford, "Optimization of Delivery of Foreign Gene into Higher Plant Chloroplasts," 15 Plant Mol. Biol. 809-19 (1990) , which is hereby incorporated by reference, and transformants were selected on kanamycin medium following two days of incubation on non-selective medium. Transgenic plants from leaf discs were regenerated from shoots after transfer to a hormone-free tobacco medium. 20 μg tunicamycin per ml was added to the culture medium to inhibit
glycosylation of the fusion -glucuronidase. Leaf or root extracts were prepared by grinding in the extraction buffer (50 mM Tris-HCl, pH 7.5/0.15 mg phenylmethylsulfonyl fluoride/0.3 mg dithiothreitol/0.3 mg bovine serum albumin, all per ml) and removing the cell debris by centrifugation. The /3-glucuronidase fluorometric assay, described by J.H. Gould and R.M. Smith "A Non-destructive Assay for 0-glucuronidase in the Media of Plant Tissue Cultures," 7 Plant Mol. Biol. Rep. 209-16 (1989) , which disclosure is hereby incorporated by reference, was modified and used to measure enzymatic activity of S-glucuronidase in leaves (Figure 2A) or roots (Figure 2B) of transgenic plants. 2 μl samples were added to 50 μl of 4-methylumbelliferyl glucuronide (MUG) assay solution, and the mixtures were incubated at 37°C for 1 hour before stopping the reactions with 50 μl of stop buffer. 1 μl of each stopped reaction mixture was assayed in 1 ml of stop buffer using a DNA Fluorometer (Model TKO 100, Hoefer Scientific Instruments, San Francisco) . /3-glucuronidase activity was expressed as picomoles of 4-methylumbelliferone liberated per min per μg of total proteins. The results were from three independent experiments with each extract prepared from either leaves (Figure 2A) or roots (Figure 2B) of transgenic plants. In Figures 2A and 2B, GUS(-) and GUS(+) represent the plants transformed with pMON316-β-glucuronidase (-) and pMON316-β-glucuronidase (+) , respectively, while GUSl-1 and GUS1-2 represent plants transformed with the similar vicilin(s) signal peptide/3-glucuronidase-encoding constructs pMON316-β-glucuronidasel-l and pMON316-β-glucuronidase 1-2.
Almost no β-glucuronidase activity was detected in leaves (Fig. 2A) or roots (Fig. 2B) of transgenic plants containing the fusion gene encoding for signal peptide//3-=glucuronidase (pMON316-β-glucuronidasel-l or pMON316-β-glucuronidasel-2 ) , whereas the normal level of 0-glucuronidase activity was observed in the positive control plants transformed with pMON316-β-glucuronidase(+) . In the same experiments, no jS-glucuronidase activity was found in the
negative control plants transformed with the construct of an anti-sense S-glucuronidase gene [i.e. pMON316-β-glucuronidase (-) ] . Since the fusion region of the hybrid gene encoding for jS-glucuronidase was sequenced, and confirmed to be correct, the absence of 8-glucuronidase activity in the plants containing the fusion gene must be attributed to the interference of gene expression by the addition of the signal peptide sequence. Alternatively, the gene fusion or post-translational modification of the fusion protein in the transport pathway could cause loss of /3-glucuronidase activity.
Inactivation of the /S-glucuronidase enzyme by the gene fusion was unlikely since j8-glucuronidase had been shown to be remarkably tolerant to N-terminal modification. See R.A. Jefferson, "Assaying Chimeric Genes in Plants: the 3-glucuronidase Gene Fusion System," 5 Plant Mol. Biol. Rep. 387-405 (1987) ; G. Iturriaga, R.A. Jefferson, and M.W. Bevan, "Endoplasmic Reticulum Targeting and Glycosylation of Hybrid Proteins in Transgenic Tobacco," 1 Plant Cell 381-90 (1989) ("Iturriaga") ; and J. Denecke, J. Botter an, and R. Deblaere, "Protein Secretion in Plant Cells can Occur via a Default Pathway," 2 Plant Cell 51-59 (1990), which are hereby incorporated by reference. To test this possibility, experiments were carried out in which the transformants were treated with tunicamycin, an inhibitor of glycosylation. /3-glucuronidase activity increased significantly, two days after tunicamycin treatment, in the tobacco containing the hybrid DNA molecule of the present invention, while the j8-glucuronidase activity of the positive control plants expressing the jS-glucuronidase encoding gene was not significantly affected by tunicamycin (Fig. 2B) . Negative controls were unaffected by tunicamycin. This, together with the similar report in Iturriaga, provides strong evidence that the signal peptide efficiently directed 3-glucuronidase to the rough endoplasmic reticulum, and that N-glycosylation occurred.
Example 3 - Secretion of /3-glucuronidase into the Extracellular Space of Tobacco Cells
Protoplasts were prepared from leaves derived from seedlings of N. tabacum var Havana cv 423 grown in vitro at low light intensity, generally as described by J.I. Negy and P. Maliga, "Callus Induction and Plant Regeneration from Mesophyll Protoplasts of Nicotiana Sylvestris." 78 Z. Pflanzenphvsiol 453-55 (1976) , which disclosure is hereby incorporated by reference, with some modifications. Briefly, the sliced leaves were digested in an isolation medium containing 1.25% Cellulase RIO and 0.4% Macerozyme RIO (Karlan Chemical Corporation, Torrance, CA) at 26°C overnight. Debris was removed by filtering the mixture through a 59 μm mesh and the protoplasts were then collected at the surface of the isolation medium after a spin at lOOxg for 5 minutes. The protoplasts were resuspended in the isolation medium, and 1 ml of W5 solution, as described by I. Negrutiu, R. Shillito, I. Potrykus, G. Biasini, and F. Sala, "Hybrid Genes in the Analysis of Transformation Conditions," 8 Plant Mol. Biol. 363-73 (1987) ("Negrutiu") , which is hereby incorporated by reference, was layered on top of the protoplast suspension. After centrifugation at lOOxg for 5 minutes, the protoplasts at the interface were transferred to new tubes and washed with W5 solution. The isolated protoplasts were transformed with the plasmid constructs described above using the polyethylene glycol method of Negrutiu. The transformed protoplasts were then cultured at the final density of lxlO6 protoplasts/ml in the culture medium (containing 20 μg tunicamycin/ml where indicated) at 26°C in the dark. The transformed tobacco protoplasts were fractionated into extracellular, cytoplasmic and membrane-associated fractions about 50 hours after the polyethylene glycol-mediated transformation. The extracellular fraction (the culture medium) was collected as supernatant from the protoplast cultures following centrifugation at lOOxg for 5 minutes. The pelleted protoplasts were washed once in W5 solution and lysed by
osmotic shock in an appropriate volume of extraction buffer
(50 mM Tris-HCl pH 7.5/0.15 mg phenylmethylsulfonyl fluoride/0.3 mg dithiothreitol/0.3 mg bovine serum albumin, all per ml) . The cytoplasmic fraction was recovered as supernatant following centrifugation at 16,000xg at 4°C for 5 minutes. The pellet was washed once in extraction buffer, and resuspended and sonicated in the same buffer with 0.1% Triton
X-100. The membrane-associated fraction was then obtained as supernatant after removal of residual cell debris.
/3-glucuronidase fluorometric assay was conducted to measure enzymatic activity of jS-glucuronidase in different fractions of transformed protoplasts. The results of this assay are plotted in Figures 3A and 3B where Ex, C, and M refer to the extracellular, cytoplasmic, and membrane- associated fractions, respectively.
In the absence of tunicamycin, no 3-glucuronidase activity was detected in either extracellular or membrane- associated fractions of the protoplasts expressing the gene encoding for j8-glucuronidase or the hybrid thereof (Fig. 3A) . However, after tunicamycin treatment, a significant amount of /3-glucuronidase activity was observed in the extracellular and membrane fractions of the protoplasts transformed with the hybrid gene but not those transformed with the gene encoding S-glucuronidase (Fig. 3B) . These results suggest that some of the hybrid j8-glucuronidase enzyme was directed to the rough endoplasmic reticulum, glycosylated in the lumen of the rough endoplasmic reticulum, and secreted from the protoplasts. Secretion of /3-glucuronidase enzyme fused to the signal peptide of Pisum vicilin (s) (which normally directs protein deposition into protein bodies) supports previous studies showing that secretion can occur via a "default pathway," as disclosed by R. Bassuner, A. Huth, R. Manteuffel, and T.A. Rapoport, "Secretion of Plant Storage Globulin Polypeptides by Xenopus Laevis Oocytes, " 133 Eur. J. Biochem 321-26 (1983) ; M.M. Bustos, V.A. Luckow, L.R. Griffing, M.D. Summers, and T.C. Hall, "Expression, Glycosylation, and Secretion and Phaseolin in a Baculovirus System," 10 Plant Mol. Biol. 475-88 (1988) ; J. Denecke, J. Botterman, and R. Deblaere, "Protein Secretion in Plant Cells can Occur via a
Default Pathway," 2 Plant Cell 51-59 (1990) ("Denecke"), which are hereby incorporated by reference. That is, proteins migrate nonspecifically from the lumen of the rough endoplasmic reticulum via the Golgi complex to outer cell surfaces unless they contain signals for directed transport to other cell compartments. Since only a small proportion (-20%) of j8-glucuronidase enzyme produced in the transformed protoplasts was transported into the extracellular medium, most of the rough endoplasmic reticulum-processed /3-glucuronidase enzyme may have been transported intracellularly to be deposited in membrane-bound vesicles. This is supported by the observed increase in cytoplasmic /3-glucuronidase activity of the protoplasts producing the hybrid jS-glucuronidase after tunicamycin treatment (Fig. 3) . Alternatively, inefficient secretion may reflect a structural restriction of the S-glucuronidase enzyme, limiting its transport via the secretory pathway, as described by Denecke. In contrast to the results from transgenic tobacco plants (Fig. 2) , a comparable amount of jS-glucuronidase activity was found in the cytoplasmic fractions of tobacco protoplasts transiently expressing either the gene encoding for jS-glucuronidase or the hybrid jS-glucuronidase thereof whether or not tunicamycin was present (Fig. 3) . Similar results were obtained with most transgenic Nicotiana tabacum cells when stained with the j8-glucuronidase substrate mixture. The apparent difference between levels of β-glucuronidase activity in leaf or root cytoplasm versus callus or protoplast cytoplasm can best be explained by the very high levels of expression of the gene encoding for β-glucuronidase found in the latter two cell types. At very high expression levels, the transport system appears to become saturated or partially blocked, resulting in accumulation of 3-glucuronidase in the cytoplasm. For example, the protoplasts transiently expressing the hybrid gene produced 10-30 fold more j8-glucuronidase protein (Fig. 4) than the transgenic plants containing the same construct (Fig. 2) .
Example 4 - Enhanced expression of the hybrid gene encoding for signal peptide/3-glucuronidase by the signal peptide
We have also observed that total /3-glucuronidase activity in the hybrid gene transformants is substantially greater than the positive control gene encoding jS-glucuronidase transformants after treatment with tunicamycin (Fig. 4) . This was determined by transforming 2xl06 protoplasts with 40 μg of DNA of respective constructs as described in Example 3. This data was inconsistent with that reported by S.J. Rothstein, CM. Lazarus, W.E. Smith, D.C. Baulcombe, A.A. Gatenby, "Secretion of a Wheat Alpha-amylase Expressed in Yeast," 308 Nature 663-65 (1984) and Denecke, which showed that their signal peptides dramatically reduced synthesis of hybrid proteins. These different findings may result form the use of different signal peptides, which could affect the synthesis of the attached proteins negatively or positively. It is conceivable that the nucleotide sequence and codon usage at the N-terminus of a protein have a strong influence on transcription and translation efficiency, respectively. This data indicates that the signal peptide used in this study allows higher levels of expression of passenger proteins — a significant improvement over prior art efforts utilizing a signal peptide sequence to transport an attached heterologous protein into the endoplasmic reticulum for secretion.
Although the invention has been described in detail for the purpose of illustration, it is understood that such detail is solely for that purpose, and variations can be made therein by those skilled in the art without departing from the spirit and scope of the invention which is defined by the following claims.
Claims
1. A DNA molecule encoding for a hybrid protein comprising a first protein comprised of a signal peptide sequence derived from a vicilin signal peptide, its homologs, or a fragment thereof fused to a second protein which confers an extracellular protective effect or another desired effect to plant cells.
2. A DNA molecule according to claim 1, wherein said second protein is selected from the group consisting of proteins, their homologs, or fragments thereof which impart bacterial, fungal, insect, and freeze resistance to extracellular surfaces of plant cells, which modify cell walls, or are otherwise useful.
3. A DNA molecule according to claim 2, wherein said second protein is selected from the group consisting of chitanases, glucanases, protease inhibitors, insect-specific neurotoxins, antifreeze peptides, lytic peptides, polygalacturonidase, and fragments or portions thereof.
4. A DNA molecule according to claim 2, wherein said second protein is β-glucuronidase, a homolog, fragment, or portion thereof, or a similar marker or color protein.
5. A DNA molecule according to claim 1, wherein said DNA molecule encodes for an amino acid signal sequence substantially comprising the sequence:
Met Leu Leu Ala lie Ala Phe Leu Ala Ser Val Cys Val Ser Ser.
6. A DNA molecule according to claim 5, wherein said DNA molecule has a sequence substantially corresponding to the nucleotide sequence:
ATG TTA TTA GCT ATT GCA TTT TTA GCA TCA GTT TGT GTT TCA TCA TAC AAT AAT CGA TAA CGT AAA AAT CGT AGT CAA ACA CAA AGT AGT.
7. A recombinant DNA expression system comprising an expression vector into which is inserted a heterologous DNA molecule encoding for a hybrid protein comprising a first protein comprised of a signal peptide derived from a vicilin signal peptide, its homolog, or a fragment thereof fused to a second protein which confers an extracellular protective effect or another desired effect to plant cells.
8. A recombinant DNA expression system according to claim 7, wherein said heterologous DNA is inserted into said vector in proper orientation and correct reading frame.
9. A recombinant DNA expression system according to claim 7, wherein said second protein is selected from the group consisting of proteins, their homologs, or fragments thereof which impart bacterial, fungal, insect, and freeze resistance to extracellular surfaces of plant cells, which modify cell walls, or are otherwise useful.
10. A recombinant DNA expression system according to claim 7, wherein said second protein is /3-glucuronidase, a homolog, or a fragment or portion thereof, or a similar marker or color protein.
11. A recombinant DNA expression system comprising the DNA molecule of claim 5.
12. A recombinant DNA expression system comprising the DNA molecule of claim 6.
13. A cell transformed with the recombinant DNA expression vector of claim 7.
14. A cell transformed with a recombinant DNA expression vector containing the DNA molecule according to claim 5.
15. A cell transformed with a recombinant DNA expression vector containing the DNA molecule according to claim 6.
16. A hybrid protein comprising a first protein comprised of a signal peptide derived from a vicilin signal peptide, its homolog, or a fragment thereof fused to a second protein which confers an extracellular protective effect or another desired effect in plant cells.
17. A hybrid protein according to claim 16, wherein said second protein is selected from the group consisting of proteins, or fragments thereof, which impart bacterial, fungal, insect, and freeze resistance to extracellular surfaces of plant cells, which modify cell walls, or are otherwise useful.
18. A hybrid protein according to claim 17, wherein said second protein is 3-glucuronidase, a homolog or a fragment thereof, or a similar marker or color protein.
19. A hybrid protein according to claim 16, wherein said first protein is encoded by a gene encoding for an amino acid signal sequence substantially comprising the sequence:
Met Leu Leu Ala lie Ala Phe Leu Ala Ser Val Cys Val Ser Ser.
20. A process of producing a recombinant hybrid protein comprising: growing host cells transformed with a recombinant DNA expression vector comprising an expression system into which is inserted a heterologous DNA molecule encoding a hybrid protein comprising a signal peptide derived from a vicilin signal sequence, its homolog, or a fragment thereof fused to a second protein having an extracellular protective effect or another desired effect in plant cells and expressing the heterologous DNA molecule in said host cells to produce the hybrid protein.
21. A process according to claim 20 further comprising: harvesting the hybrid protein produced by said expressing.
22. A process according to claim 20 further comprising: passing the hybrid protein produced by said expressing into the endoplasmic reticulum of the host cell, wherein the signal peptide is cleaved from the hybrid protein during said passing; conveying the second protein having an extracellular protective effect or any other desired effect in plants to the Golgi complex of the host cell, wherein the second protein is modified by glycosylation; and secreting the modified second protein from the Golgi complex to a location extracellular to the host cell or otherwise transporting the second protein within the cell.
23. A process according to claim 20, wherein said DNA molecule encodes for an amino acid signal sequence substantially comprising the sequence:
Met Leu Leu Ala lie Ala Phe Leu Ala Ser Val Cys Val Ser Ser.
24. A process according to claim 23, wherein said DNA molecule has a sequence substantially corresponding to the nucleotide sequence:
ATG TTA TTA GCT ATT GCA TTT TTA GCA TCA GTT TGT GTT TCA TCA TAC AAT AAT CGA TAA CGT AAA AAT CGT AGT CAA ACA CAA AGT AGT.
25. A cellular transport process comprising: directing a protein into the endoplasmic reticulum of a plant cell with a signal peptide derived from a vicilin signal peptide, its homolog, or a fragment hereof.
26. A hybrid fusion gene encoding for a signal peptide sequence derived from a vicilin signal peptide fused to another protein.
27. A hybrid fusion protein comprising a signal peptide sequence derived from a vicilin signal peptide fused to another protein.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85142992A | 1992-03-13 | 1992-03-13 | |
US07/851,429 | 1992-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993018181A1 true WO1993018181A1 (en) | 1993-09-16 |
Family
ID=25310749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/001494 WO1993018181A1 (en) | 1992-03-13 | 1993-02-19 | Synthetic gene sequence for a signal peptide |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1993018181A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006501818A (en) * | 2002-07-23 | 2006-01-19 | デルタ バイオテクノロジー リミテッド | Gene and polypeptide sequences |
WO2019241315A1 (en) | 2018-06-12 | 2019-12-19 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
WO2020086742A1 (en) | 2018-10-24 | 2020-04-30 | Obsidian Therapeutics, Inc. | Er tunable protein regulation |
WO2020185632A1 (en) | 2019-03-08 | 2020-09-17 | Obsidian Therapeutics, Inc. | Human carbonic anhydrase 2 compositions and methods for tunable regulation |
WO2020252405A1 (en) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
WO2020252404A1 (en) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
WO2021046451A1 (en) | 2019-09-06 | 2021-03-11 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940840A (en) * | 1984-03-26 | 1990-07-10 | Dna Plant Technology Corporation | Novel chitinase-producing bacteria and plants |
-
1993
- 1993-02-19 WO PCT/US1993/001494 patent/WO1993018181A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940840A (en) * | 1984-03-26 | 1990-07-10 | Dna Plant Technology Corporation | Novel chitinase-producing bacteria and plants |
Non-Patent Citations (5)
Title |
---|
GENE, Volume 99, No. 1, issued 01 March 1991, M. DE LOOSE et al., "The Extensin Signal Peptide Allows Secretion of a Heterologous Protein form Protoplasts", pages 95-100. * |
NUCLEIC ACIDS RESEARCH, Volume 11, No. 8, issued 1983, "The Vicilin Gene Family of Pea (Pisum Sativum L.): A Complete cDNA Coding Sequence for Preprovicilin", pages 2367-2380. * |
PLANT MOLECULAR BIOLOGY, Volume 11, issued 1988, T.J.V. HIGGINS et al., "The Sequence of a Pea Vicilin Gene and its Expression in Transgenic Tobacco Plants", pages 683-695. * |
PLANT PHYSIOLOGY, Volume 91, issued 1989, P. LUND et al., "Bacterial Chitanse is Modified and Secreting in Transgenic Tobacco", pages 130-135. * |
THE PLANT CELL, Volume 1, issued March 1989, G. ITURRIAGA et al., "Endoplasmic Reticulum Targeting and Glycosylation of Hybrid Proteins in Transgenic Tobacco", pages 381-390. * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006501818A (en) * | 2002-07-23 | 2006-01-19 | デルタ バイオテクノロジー リミテッド | Gene and polypeptide sequences |
EP2390333A1 (en) * | 2002-07-23 | 2011-11-30 | Novozymes Biopharma DK A/S | Polypeptides comprising a modified human serum albumin secretion pre-sequence with improved secretion yield |
US8258102B2 (en) | 2002-07-23 | 2012-09-04 | Novozymes Biopharma Dk A/S | Gene and polypeptide sequences |
US9133265B2 (en) | 2002-07-23 | 2015-09-15 | Novozymes Biopharma Dk A/S | Gene and polypeptide sequences |
WO2019241315A1 (en) | 2018-06-12 | 2019-12-19 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
WO2020086742A1 (en) | 2018-10-24 | 2020-04-30 | Obsidian Therapeutics, Inc. | Er tunable protein regulation |
WO2020185632A1 (en) | 2019-03-08 | 2020-09-17 | Obsidian Therapeutics, Inc. | Human carbonic anhydrase 2 compositions and methods for tunable regulation |
WO2020252405A1 (en) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
WO2020252404A1 (en) | 2019-06-12 | 2020-12-17 | Obsidian Therapeutics, Inc. | Ca2 compositions and methods for tunable regulation |
WO2021046451A1 (en) | 2019-09-06 | 2021-03-11 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bednarek et al. | A carboxyl-terminal propeptide is necessary for proper sorting of barley lectin to vacuoles of tobacco. | |
US5650307A (en) | Production of heterologous proteins in plants and plant cells | |
US5650554A (en) | Oil-body proteins as carriers of high-value peptides in plants | |
EP0392225B1 (en) | Disease-resistant transgenic plants | |
JP5517309B2 (en) | Collagen producing plant and method for producing the same | |
Kavanagh et al. | Targeting a foreign protein to chloroplasts using fusions to the transit peptide of a chlorophyll a/b protein | |
US5665579A (en) | Invertase genes and uses thereof | |
CA2110772A1 (en) | Ltp2 promoter having aleurone-specific activity | |
AU2002333330A1 (en) | Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies | |
JP2004516003A (en) | Synthetic genes for vegetable rubber and other hydroxyproline-rich glycoproteins | |
Saalbach et al. | The vacuolar targeting signal of the 2S albumin from Brazil nut resides at the C terminus and involves the C-terminal propeptide as an essential element | |
FI120266B (en) | Oil cavity proteins as carriers of precious peptides in plants | |
Bosch et al. | A trout growth hormone is expressed, correctly folded and partially glycosylated in the leaves but not the seeds of transgenic plants | |
AU2005308922B2 (en) | Protein isolation and purification | |
US20080010697A1 (en) | Methods of Expressing Heterologous Protein in Plant Seeds Using Monocot Non Seed-Storage Protein Promoters | |
WO1993018181A1 (en) | Synthetic gene sequence for a signal peptide | |
EP1003840A1 (en) | Synthetic genes for plant gums | |
Napier et al. | Trafficking of wheat gluten proteins in transgenic tobacco plants: γ-gliadin does not contain an endoplasmic reticulum-retention signal | |
US20070039073A1 (en) | Novel synthetic genes for plant gums | |
Pang et al. | Use of the signal peptide of Pisum vicilin to translocate β-glucuronidase in Nicotiana tabacum | |
EP2518081B1 (en) | Method of producing and purifying polymeric proteins in transgenic plants | |
US7557264B2 (en) | Gossypium hirsutum tissue-specific promoters and their use | |
US20040117874A1 (en) | Methods for accumulating translocated proteins | |
US5525713A (en) | DNA encoding polypeptides enabling sorting of proteins to vacuoles in plants | |
Le | The BURP domain protein family of Arabidopsis: a novel component related to seed development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
122 | Ep: pct application non-entry in european phase |